APA način citiranja

Polena, H., Creuzet, J., Dufies, M., Sidibé, A., Khalil-Mgharbel, A., Salomon, A., . . . Vilgrain, I. (2018). The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: A marker of response to antitumoural treatment in metastatic renal cell carcinoma. Br J Cancer.

Čikaški stil citiranja

Polena, Helena, et al. "The Tyrosine-kinase Inhibitor Sunitinib Targets Vascular Endothelial (VE)-cadherin: A Marker of Response to Antitumoural Treatment in Metastatic Renal Cell Carcinoma." Br J Cancer 2018.

MLA način citiranja

Polena, Helena, et al. "The Tyrosine-kinase Inhibitor Sunitinib Targets Vascular Endothelial (VE)-cadherin: A Marker of Response to Antitumoural Treatment in Metastatic Renal Cell Carcinoma." Br J Cancer 2018.